TherageniX and University of Nottingham Awarded £995K Innovate UK grant to develop powdered gene therapy for bone regeneration
London, UK, and Nottingham, UK - TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation agency. The funding will support the development of the Company’s gene therapy in a powder, a non-viral gene…
Yourgene Health presents data demonstrating successful Fetal Fraction Enrichment in NIPT Workflows following prolonged blood storage in EDTA Tubes
• Extended EDTA blood tube storage offers improved flexibility and cost-saving in NIPT workflows • Collaborative study with Tommy’s Charity and St Mary’s NHS Hospital, Manchester
ELRIG UK Announces Prof Janet Hemingway and Dr Dave Powell as Keynote Speakers at Drug Discovery 2023
ELRIG Drug Discovery 2023 at ACC Liverpool (18–19 October) to focus on diverse thinking and new perspectives
ELRIG UK appoints Nick Clare to Board as Vendor Strategy Work Group Lead
Cambridge, UK - The European Laboratory Research & Innovation Group (ELRIG) UK announces the appointment of Nick Clare to the ELRIG board. He will chair and lead the Vendor Strategy Work Group to help ensure the vendors’ perspectives and interests are represented within the ELRIG board.